Medical research group Roswell Park Cancer Institute has finalized a deal with the Center for Molecular Immunology of Cuba to bring a lung cancer vaccine called Cimavax to the United States.
Medical research group Roswell Park Cancer Institute has finalized a deal with the Center for Molecular Immunology of Cuba to bring a lung cancer vaccine called Cimavax to the United States.
Share this Article
Recommended